الفهرس 
INTRODUCTIONOnly 14 pages are availabe for public view
 |  | from | 141 |  |  |
| | | from | 141 | | |
Abstract
Background:
Triple negative breast carcinomas (TNBCs) are a group of primary breast tumors
with aggressive clinical behavior that have no targeted therapy at present. EGFR
expression has recently come into focus as an index for molecular targeting
therapy. Histologic sections that included variable subtypes and grades of
TNBCs were studied by immunohistochemistry with EGFR, using a standard
avidin–biotin–peroxidase system.
Results: Twenty two cases showed variable positive reactivity for EGFR (55%
of total cases).
Conclusions: the level of EGFR expression was relatively high as most studies
stated, and agreed with most studies about the statement that EGFR expression is
associated with worse prognosis.
Key Words: Triple, negative, TNBC, EGFR.